A new study in Clinical Epidemiology and Global Health features the Glivec®Patient Assistance Program (GIPAP) and reveals that “chronic myelocytic leukemia (CML) is diagnosed at an earlier age in poorer populations than in more affluent populations.” The study focused on India’s CML population to investigate other possible contributors to early age at onset. The team of authors include our very own South Asia Region Head Viji Venkatesh, and Max CEO Pat Garcia-Gonzalez, as well as Paul H. Levine, Kunal Ajmera, Brenna O’Neill, Heather J. Hoffman.
The study is only available to the public for a limited time so if you know a physician or researcher that would benefit from this study, share it today!
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Janaki is a happy 22-year-old woman living in Nepal and working at Century Bank. But this has not always been the case for her. At the ripe age of ten years old, Janaki’s physical health began to deteriorate, and her family was left searching for answers. With the financial burden being too much for her….
Physicians are an essential part of our work. We partner with more than 500 healthcare professionals who provide cancer treatment in low- and middle-income countries. They volunteer to be in our program, caring for people in need on top of their regular schedule. Dr. Mipsang Lama is a perfect example – he goes above and….
How we continue providing emotional support for people facing cancer throughout COVID-19
